JP2002526530A5 - - Google Patents

Download PDF

Info

Publication number
JP2002526530A5
JP2002526530A5 JP2000574510A JP2000574510A JP2002526530A5 JP 2002526530 A5 JP2002526530 A5 JP 2002526530A5 JP 2000574510 A JP2000574510 A JP 2000574510A JP 2000574510 A JP2000574510 A JP 2000574510A JP 2002526530 A5 JP2002526530 A5 JP 2002526530A5
Authority
JP
Japan
Prior art keywords
alkyl
cycloalkyl
conh
alkylene
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000574510A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002526530A (ja
JP4544746B2 (ja
Filing date
Publication date
Priority claimed from DE19845406A external-priority patent/DE19845406C2/de
Application filed filed Critical
Publication of JP2002526530A publication Critical patent/JP2002526530A/ja
Publication of JP2002526530A5 publication Critical patent/JP2002526530A5/ja
Application granted granted Critical
Publication of JP4544746B2 publication Critical patent/JP4544746B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000574510A 1998-10-02 1999-09-18 置換された1,3−ジアリール−2−ピリド−2−イル−3−(ピリド−2−イルアミノ)プロパノール誘導体、その製造方法、それを含有する医薬およびその使用 Expired - Fee Related JP4544746B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19845406.6 1998-10-02
DE19845406A DE19845406C2 (de) 1998-10-02 1998-10-02 Substituierte 1,3-Diaryl-2-pyridin-2-yl-3-(pyridin-2-ylamino)- propanolderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
PCT/EP1999/006933 WO2000020393A1 (de) 1998-10-02 1999-09-18 Substituierte 1,3-diaryl-2-pyridin-2-yl-3-(pyridin-2-ylamino)-propanolderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung

Publications (3)

Publication Number Publication Date
JP2002526530A JP2002526530A (ja) 2002-08-20
JP2002526530A5 true JP2002526530A5 (https=) 2006-09-07
JP4544746B2 JP4544746B2 (ja) 2010-09-15

Family

ID=7883187

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000574510A Expired - Fee Related JP4544746B2 (ja) 1998-10-02 1999-09-18 置換された1,3−ジアリール−2−ピリド−2−イル−3−(ピリド−2−イルアミノ)プロパノール誘導体、その製造方法、それを含有する医薬およびその使用

Country Status (22)

Country Link
US (1) US6596728B1 (https=)
EP (1) EP1117642B1 (https=)
JP (1) JP4544746B2 (https=)
KR (1) KR100609255B1 (https=)
CN (1) CN1173951C (https=)
AR (1) AR021845A1 (https=)
AT (1) ATE267809T1 (https=)
AU (1) AU757689B2 (https=)
BR (1) BR9915027B1 (https=)
CA (1) CA2345985C (https=)
CZ (1) CZ299569B6 (https=)
DE (2) DE19845406C2 (https=)
DK (1) DK1117642T3 (https=)
ES (1) ES2219066T3 (https=)
HU (1) HU226688B1 (https=)
ID (1) ID29249A (https=)
PL (1) PL205034B1 (https=)
PT (1) PT1117642E (https=)
RU (1) RU2224748C2 (https=)
TR (1) TR200100896T2 (https=)
WO (1) WO2000020393A1 (https=)
ZA (1) ZA200102587B (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10064402A1 (de) * 2000-12-21 2002-06-27 Aventis Pharma Gmbh Diphenylazetidinonderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
AU2002231688A1 (en) 2000-12-21 2002-07-01 Sanofi-Aventis Deutschland Gmbh Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use
PL366855A1 (en) * 2001-08-22 2005-02-07 Aventis Pharma Deutschland Gmbh Combination preparations of aryl substituted propanolamine derivatives with other active ingredients and the use thereof
US7161008B2 (en) * 2002-05-03 2007-01-09 Sanofi - Aventis Deutschland GmbH Optically active β-aminoketones, optically active 1,3-amino alcohols and processes for preparing them
DE10219987A1 (de) * 2002-05-03 2004-04-08 Aventis Pharma Deutschland Gmbh Optisch aktive β-Aminoketone, optisch aktive 1,3-Aminoalkohole und Verfahren zu deren Herstellung
GB0307918D0 (en) 2003-04-05 2003-05-14 Astrazeneca Ab Therapeutic use
JP4800216B2 (ja) * 2003-10-24 2011-10-26 エグゼリクシス, インコーポレイテッド p70S6キナーゼモジュレーターおよび使用方法
EP2575821B1 (en) 2010-05-26 2015-08-12 Satiogen Pharmaceuticals, Inc. Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions
CA2852957C (en) 2011-10-28 2020-08-04 Lumena Pharmaceuticals, Inc. Bile acid recycling inhibitors for treatment of hypercholemia and cholestatic liver disease
CN104023727B (zh) 2011-10-28 2017-04-05 鲁美纳医药公司 用于治疗小儿胆汁淤积性肝病的胆汁酸再循环抑制剂
US20140275090A1 (en) 2013-03-15 2014-09-18 Lumena Pharmaceuticals, Inc. Bile acid recycling inhibitors for treatment of primary sclerosing cholangitis and inflammatory bowel disease
CN105228615A (zh) 2013-03-15 2016-01-06 鲁美纳医药公司 用于治疗巴雷特食管和胃食管返流疾病的胆汁酸再循环抑制剂
JP6361168B2 (ja) * 2013-06-17 2018-07-25 Jsr株式会社 液晶配向剤、液晶配向膜、液晶表示素子、液晶表示素子の製造方法、重合体及び化合物
PL3923943T3 (pl) 2019-02-12 2024-12-09 Mirum Pharmaceuticals, Inc. Zależna od genotypu i dawki odpowiedź na asbti u pacjentów z niedoborem pompy eksportu soli żółciowych

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0000816A1 (en) * 1977-08-06 1979-02-21 Beecham Group Plc Substituted amino-pyridine derivatives, processes for their preparation and pharmaceutical compositions containing them
SU1194273A3 (ru) * 1981-02-09 1985-11-23 Пфайзер Инк (Фирма) Способ получени пирбутерола или его аналогов
GB9203347D0 (en) * 1992-02-17 1992-04-01 Wellcome Found Hypolipidaemic compounds
DK0557879T3 (da) * 1992-02-22 1997-06-16 Hoechst Ag 4-amino-2-ureido-pyrimidin-5-carboxylsyreamider, fremgangsmåde til deres fremstilling, lægemidler med indhold af disse forbindelser og deres anvendelse
DK0869121T3 (da) 1997-04-04 2004-09-20 Aventis Pharma Gmbh Hypolipidæmiske propanolaminderivater
DE19845402B4 (de) * 1998-10-02 2005-04-07 Aventis Pharma Deutschland Gmbh Mit Heterocyclen substituierte Propanolaminderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
DE19845405C2 (de) * 1998-10-02 2000-07-13 Aventis Pharma Gmbh Arylsubstituierte Propanolaminderivate und deren Verwendung

Similar Documents

Publication Publication Date Title
JP2002526530A5 (https=)
JP2002501049A5 (https=)
JP2004532209A5 (https=)
CA2044515A1 (en) Cyclic amide derivatives
JP2004529194A5 (https=)
NO175939C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktiv N1-(1,2-cis-2-halogencyklopropyl)-substituerte pyridonkarboksylsyrederivater, eller et farmasöytisk akseptabelt salt derav, eventuelt i en stereoisomerisk form
JP2001526218A5 (https=)
JP2005508905A5 (https=)
JP2005525398A5 (https=)
JP2005505583A5 (https=)
JPH10287651A5 (https=)
JP2002526539A5 (https=)
RU2224748C2 (ru) Производные 1,3-диарил-2-пиридин-2-ил-3-(пиридин-2-иламино)пропанола и фармацевтическая композиция на их основе
RU2002130247A (ru) Производные оксадиазола, обладающие противоопухолевым действием
RU2004107854A (ru) Производные 4[пиперидин-4-илиден-(3-карбомоилфенил)метил]бензамида и их применение для лечении боли, спинальных повреждений или желудочно-кишечных расстройств
RU2006130686A (ru) Новые пиперидины в качестве модуляторов хемокинов (ccr)
JP2002539089A5 (https=)
RU2001111841A (ru) Замещенные производные 1,3-диарил-2-пиридин-2-ил-3-(пиридин-2-иламино)пропанола, способ их получения, содержащие эти соединения лекарственные средства и их применение
DE60127535D1 (de) Vorbeugende oder therapeutische mittel gegen gastrische oder ösophageale regurgitation
JP2002526550A5 (https=)
JP2002538117A5 (https=)
JP2004538314A5 (https=)
JP2002538148A5 (https=)
BR0009080A (pt) Método de tratamento da apnéia do sono
JP2007525527A5 (https=)